AI turns "impossible" into engineering backlogs; future giants in medicine and robotics
imjustnewatai · x · 2026-08-20
AI is turning entire categories of “impossible” tasks into engineering backlogs. The post advises studying companies treating AI as core infrastructure rather than a novelty, including chips, energy, data centers, robotics, drug discovery, genomics, and automated science.
The most important AI companies of the next decade might not make chatbots. Instead, they may use abundant machine intelligence to solve problems too complex, expensive, or slow for humans: designing medicines, simulating proteins, interpreting genomes, discovering new materials, automating laboratories, and compressing years of research into weeks. Eradicating age-related disease, repairing genetic disorders, and treating Alzheimer’s could become enormous industries.
AI will not make every company successful, but the deeper thesis is simple: intelligence is becoming scalable. The greatest value creation may occur at companies that turn that intelligence into real-world breakthroughs, durable advantages, and measurable revenue.
More from AGI Musings
- AI Will Hyperinflate Content, Devaluing Online Status Without Hard Assets — signulll · 2026-08-20
- Speculation on Stripe buying OpenRouter to enable automated data acquisition — andrew_n_carr · 2026-08-20
- AI inference consumption flagged as potential new money-laundering path: From fiat to compliant revenue — ChanceKelch · 2026-08-20
- Biology Will Be One of the Largest Beneficiaries from AI Advancements — BrettKrieger12 · 2026-08-20
- On formalization and AGI alignment: Understanding and doing what *we* find interesting — littmath · 2026-08-20
- 10M context window transforms legal AI workflow — Kyrannio · 2026-08-20